project id: TCGA-COAD; case submitter id: TCGA-AY-A69D; analyte type: DNA; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.8; age at index: 55; days to birth: -20299; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1957; age at diagnosis: 20299; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 543.0; icd 10 code: C18.4; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Transverse colon; synchronous malignancy: No; tissue or organ of origin: Transverse colon; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 203; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-AY-A69D-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 15.0; percent stromal cells: 25.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;